• Our Company

QuintilesIMS Delivers Integrated Information and Technology Solutions to Drive Healthcare Forward

Around the world healthcare stakeholders are working to improve real-world patient outcomes through treatment innovations, care provision and access to healthcare. For the information, technology and service solutions they need to drive new insights and approaches, they count on QuintilesIMS. With a global team of 50,000, we harness insights, commercial and scientific depth, and executional expertise to empower clients to achieve some of their most important goals: Improving clinical, scientific and commercial results. Realizing the full potential of innovations. And, ultimately, driving healthcare forward.

For more information please visit www.quintilesims.com.

Driving Healthcare Performance in Hong Kong

Established in Hong Kong in 1989, QuintilesIMS Hong Kong has one of the most comprehensive offering portfolios in the region helping clients realize the potential of the Hong Kong market. QuintilesIMS provides leading information, services and technology for the healthcare industry around the world.

Hong Kong's combined retail and hospital pharmaceutical market has experienced strong, double-digit sales growth for most of the past decade, helped by growth in the economy and a recovery of the private hospital sector. The size of the total pharmaceutical market in Hong Kong reached US$1.2 billion in 2013, reflecting a 11.1% market growth from the previous year. This level of growth is expected to continue, averaging a CAGR of 6.7% up to 2018.

The Government continues to honor its commitment to increase both overall healthcare and pharmaceutical expenditure. Subsidies made available under the Health Care Voucher Scheme will benefit the private healthcare sector, as will the increase of the Samaritan Fund for serious illnesses by HK$ 10 billion over the next 10 years. With the expansion of public and private hospitals and the development of primary care services, the market is expected to respond well to recent and future product launches. However, the continued development of the case mix funding system in HA hospitals, increasing erosion of prescribing freedom in the public sector and heightened generic competition as more high-selling products come off patent, act as negative factors threatening the market.

In today's highly competitive and complex environment, contact your QuintilesIMS Hong Kong representative to gain greater clarity and stay one step ahead of the competition with the valuable insights gained from QuintilesIMS offerings.